[go: up one dir, main page]

AU2001291678A1 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
AU2001291678A1
AU2001291678A1 AU2001291678A AU9167801A AU2001291678A1 AU 2001291678 A1 AU2001291678 A1 AU 2001291678A1 AU 2001291678 A AU2001291678 A AU 2001291678A AU 9167801 A AU9167801 A AU 9167801A AU 2001291678 A1 AU2001291678 A1 AU 2001291678A1
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
nail
onychomycosis
preparation
laser beam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291678A
Inventor
Alfredo Emilio Bruno-Raimondi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2001291678A1 publication Critical patent/AU2001291678A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Laser Surgery Devices (AREA)
  • Surgical Instruments (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A method for the topical treatment of nail diseases, e.g. onychomycosis, after preparation of the infected nail with a laser beam.
AU2001291678A 2000-08-04 2001-07-24 Pharmaceutical compositions Abandoned AU2001291678A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0019283.1A GB0019283D0 (en) 2000-08-04 2000-08-04 Organic compounds
GB0019283 2000-08-04
PCT/EP2001/008558 WO2002011764A2 (en) 2000-08-04 2001-07-24 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AU2001291678A1 true AU2001291678A1 (en) 2002-02-18

Family

ID=9897070

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291678A Abandoned AU2001291678A1 (en) 2000-08-04 2001-07-24 Pharmaceutical compositions

Country Status (10)

Country Link
US (4) US20030181847A1 (en)
EP (1) EP1307227B1 (en)
JP (3) JP2004505928A (en)
AT (1) ATE308341T1 (en)
AU (1) AU2001291678A1 (en)
DE (1) DE60114635T2 (en)
DK (1) DK1307227T3 (en)
ES (1) ES2252294T3 (en)
GB (1) GB0019283D0 (en)
WO (1) WO2002011764A2 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203276D0 (en) * 2002-02-12 2002-03-27 Novartis Ag Organic compounds
US20040126272A1 (en) * 2002-08-28 2004-07-01 Eric Bornstein Near infrared microbial elimination laser system
US20040126343A1 (en) * 2002-12-26 2004-07-01 Garshowitz Solomon David Nail drug delivery
US20050256553A1 (en) * 2004-02-09 2005-11-17 John Strisower Method and apparatus for the treatment of respiratory and other infections using ultraviolet germicidal irradiation
EP1627610A1 (en) * 2004-08-21 2006-02-22 TLT Medical Ltd Drug delivery throug application in nails
US20060153786A1 (en) * 2004-12-10 2006-07-13 Talima Therapeutics, Inc. Compositions and methods for treating conditions of the nail unit
US8277495B2 (en) 2005-01-13 2012-10-02 Candela Corporation Method and apparatus for treating a diseased nail
US20070104664A1 (en) * 2005-10-26 2007-05-10 California Institute Of Technology Treatment of toenail fungus
JP5095986B2 (en) * 2005-11-30 2012-12-12 学校法人慶應義塾 Non-nail invasive blood substance measuring device and nail plate transpiration device
CN101351189A (en) * 2006-01-02 2009-01-21 Tlt医学有限公司 Pharmaceutical composition for treating nail (toe) nail diseases
AU2007208264A1 (en) * 2006-01-24 2007-08-02 Nomir Medical Technologies, Inc. Optical method and device for modulation of biochemical processes in adipose tissue
EP2119408A1 (en) * 2008-05-16 2009-11-18 TLT Medical Ltd Photoablator
US8758730B2 (en) 2009-02-26 2014-06-24 B.R.A.I.N. Biotechnology Research And Information Network Ag Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin
NL1036661C2 (en) 2009-03-04 2010-09-07 Serrix B V Anti-fungal compounds & compositions.
EP2229980B1 (en) * 2009-03-16 2015-08-12 Nuvolase, Inc. Treatment of microbiological pathogens in a toe nail with antimicrobial light
US8814922B2 (en) * 2009-07-22 2014-08-26 New Star Lasers, Inc. Method for treatment of fingernail and toenail microbial infections using infrared laser heating and low pressure
DE102009038512A1 (en) * 2009-07-30 2011-02-10 Technische Universität Braunschweig Use of formulation comprising a substance, polyether polyol, preferably e.g. polyethylene glycol, dimethyl isosorbide, triglyceride, alcohol, preferably ethanol or isopropanol and residual water, to treat nail and/or nail bed disease
WO2011071137A1 (en) * 2009-12-10 2011-06-16 学校法人慶應義塾 Therapeutic system for onychomycosis
FR2954164B1 (en) * 2009-12-18 2012-03-16 Galderma Pharma Sa ANTIFUNGAL COMPOSITION INTENDED TO BE APPLIED ON THE PERFORATED NAIL
ES3006882T3 (en) 2011-02-24 2025-03-19 Eximo Medical Ltd Hybrid catheter for vascular intervention
JP2015516215A (en) * 2012-04-20 2015-06-11 ガルデルマ・リサーチ・アンド・デヴェロップメント Optimization of nail treatment by quantitative autoradiography
WO2014118738A1 (en) * 2013-01-31 2014-08-07 Eximo Medical Ltd. Hybrid catheter apparatus and methods
US12514456B2 (en) 2013-01-31 2026-01-06 Eximo Medical Ltd. System and methods for lesion characterization in blood vessels
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
US9504849B2 (en) * 2013-03-14 2016-11-29 Plumeria Holdings, Llc Destruction of target cells utilizing harmonic resonance cavitation
US10420608B2 (en) 2014-05-20 2019-09-24 Verily Life Sciences Llc System for laser ablation surgery
US11684420B2 (en) 2016-05-05 2023-06-27 Eximo Medical Ltd. Apparatus and methods for resecting and/or ablating an undesired tissue
ES2986383T3 (en) 2018-08-01 2024-11-11 Edix O Sarl Injectable compounds with long-lasting effect for use as a treatment for nail diseases
EP3603650A1 (en) 2018-08-01 2020-02-05 Edix O Sarl Injectable and prolonged action compositions for use in the treatment of diseases of the nail and/or to accelerate nail growth
US11224378B2 (en) * 2019-03-15 2022-01-18 Blossom Innovations, LLC Therapeutic laser system and method
JP7524208B2 (en) * 2019-03-15 2024-07-29 ザ ジェネラル ホスピタル コーポレイション Systems and methods for laser-assisted localized treatment of fungal nail infections - Patents.com
WO2020190376A1 (en) * 2019-03-15 2020-09-24 The General Hospital Corporation Systems and methods for laser-assisted topical treatment of nail fungal infections
US12376904B1 (en) 2020-09-08 2025-08-05 Angiodynamics, Inc. Dynamic laser stabilization and calibration system
US12038322B2 (en) 2022-06-21 2024-07-16 Eximo Medical Ltd. Devices and methods for testing ablation systems

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180058A (en) * 1978-08-15 1979-12-25 Jacob Brem Method of treating pathological conditions of the nail
JPS5821387A (en) * 1981-07-29 1983-02-08 Olympus Optical Co Ltd Irradiator for laser
US4525842A (en) * 1984-02-24 1985-06-25 Myers John D Laser device and method
US4826513A (en) * 1987-01-12 1989-05-02 Stackhouse Wyman H Laser smoke particulate/odor filter system
US4767333A (en) * 1987-08-17 1988-08-30 Born Grant R Laser evolved models
EP0368512A3 (en) * 1988-11-10 1990-08-08 Premier Laser Systems, Inc. Multiwavelength medical laser system
US5168454A (en) * 1989-10-30 1992-12-01 International Business Machines Corporation Formation of high quality patterns for substrates and apparatus therefor
FR2673537B1 (en) * 1991-03-08 1993-06-11 Oreal USE OF HYDROPHILIC PENETRATION AGENTS IN DERMATOLOGICAL COMPOSITIONS FOR THE TREATMENT OF ONYCHOMYCOSES, AND CORRESPONDING COMPOSITIONS.
HU219480B (en) * 1991-05-23 2001-04-28 Novartis Ag. A method for the preparation of topical medicaments containing an allylamine derivative for the treatment of fungal circulatory diseases.
US6315772B1 (en) * 1993-09-24 2001-11-13 Transmedica International, Inc. Laser assisted pharmaceutical delivery and fluid removal
US5643252A (en) * 1992-10-28 1997-07-01 Venisect, Inc. Laser perforator
US6716210B2 (en) * 1992-12-03 2004-04-06 Lasersight Technologies, Inc. Refractive surgical laser apparatus and method
US5885211A (en) * 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
US5554153A (en) * 1994-08-29 1996-09-10 Cell Robotics, Inc. Laser skin perforator
EP0866683A4 (en) * 1995-09-14 1999-01-07 Sorenson Pharmaceutical Inc Composition and method for treating diseased nails
US5782249A (en) * 1996-09-30 1998-07-21 Weber; Paul J. Laser manicure process
SE9604610D0 (en) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
CA2298526A1 (en) * 1997-07-28 1999-02-04 Dermatolazer Technologies Ltd Phototherapy based method for treating pathogens and composition for effecting same
US5947956A (en) * 1997-11-04 1999-09-07 Karell; Manuel Leon Laser apparatus for making holes and etchings
US5994383A (en) * 1997-11-18 1999-11-30 Woodward Laboratories, Inc. Surfactant-based antimicrobial compositions and methods for using the same
US6286517B1 (en) * 1998-12-22 2001-09-11 Pearl Technology Holdings, Llc Fingernail and toenail decoration using ink jets
US6449294B1 (en) * 1999-07-26 2002-09-10 Pls Liquidating Llc Single dominant spike output erbium laser
US6403063B1 (en) * 1999-07-26 2002-06-11 Kenneth I. Sawyer Method of treating nail fungus
JP2001235850A (en) * 2000-02-24 2001-08-31 Sony Corp Method for designing photomask pattern, method for forming resist pattern, and method for manufacturing semiconductor device
DE10017996A1 (en) * 2000-04-11 2001-10-18 Pierre Foss New terbinafine tablets and a regimen for the treatment of onychomycosis
US6706032B2 (en) * 2000-06-08 2004-03-16 Massachusetts Institute Of Technology Localized molecular and ionic transport to and from tissues
US20080306471A1 (en) * 2000-12-28 2008-12-11 Palomar Medical Technologies, Inc. Methods and devices for fractional ablation of tissue
AU2002316500A1 (en) * 2001-07-02 2003-01-21 Palomar Medical Technologies, Inc. Laser device for medical/cosmetic procedures
US7220254B2 (en) * 2003-12-31 2007-05-22 Palomar Medical Technologies, Inc. Dermatological treatment with visualization
US20050256552A1 (en) * 2004-05-17 2005-11-17 White Robert L Toenail fungus eradicator

Also Published As

Publication number Publication date
US20100113607A1 (en) 2010-05-06
US20070004756A1 (en) 2007-01-04
WO2002011764A3 (en) 2002-04-25
WO2002011764A2 (en) 2002-02-14
EP1307227A2 (en) 2003-05-07
EP1307227B1 (en) 2005-11-02
JP2011132247A (en) 2011-07-07
GB0019283D0 (en) 2000-09-27
ATE308341T1 (en) 2005-11-15
US20030181847A1 (en) 2003-09-25
ES2252294T3 (en) 2006-05-16
JP2008132349A (en) 2008-06-12
JP2004505928A (en) 2004-02-26
US20110082448A1 (en) 2011-04-07
DE60114635D1 (en) 2005-12-08
DK1307227T3 (en) 2006-03-06
DE60114635T2 (en) 2006-07-20

Similar Documents

Publication Publication Date Title
AU2001291678A1 (en) Pharmaceutical compositions
SE0100901D0 (en) New composition
AR032293A1 (en) PHARMACEUTICAL CASE
EP2261200A3 (en) Modified forms of pharmacacologically active agents and uses therefor
NO20030374D0 (en) Cyclopentanoindoles, preparations containing such compounds and treatment methods
WO2002053516A3 (en) N(phenylsulphonyl)glycine derivatives and their therapeutic use
NO20011721D0 (en) N-aralkylaminotetralins as ligands for neuropeptide Y Y5 receptor
EE200400020A (en) Substituted oxazolidinones for combination therapy
PA8559401A1 (en) SUCCINIC ACID SALTS OF 5,7,14-TRIAZATETRACICLO (10.3.1.0 2,11.0 4, 9) -HEXADECA-2 (11), 3,5,7,9-PENTAENO AND PHARMACEUTICAL COMPOSITIONS OF THE SAME.
BR0306870A (en) Oral pharmaceutical composition and method for preparing the same
CY1110258T1 (en) Substituted C-cyclohexylmethylamine derivatives
AU3475097A (en) Substituted cyclopentane compounds useful as neuraminidase inhibitors
NO20023551D0 (en) Ibuprofen-containing active agent preparation
AR012504A1 (en) USE OF TETRAHYDROPYRIDINE DERIVATIVES, FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES WHICH CAUSE A DEMELINATION.
DK1121127T3 (en) Oral pharmaceutical compositions containing buprenorphine
AR021750A1 (en) APPARATUS FOR THE LOCALIZED TOPIC TREATMENT OF A DISEASE
AU2001234089A1 (en) Cancer remedy comprising anthranilic acid derivative as active ingredient
PT1150704E (en) MELAGATRAN FOR THE TREATMENT OF INFLAMMATION
ATE253359T1 (en) ANTITHRBOTIC AGENTS
BR0114380A (en) 1-Aminobutan-3-ol-substituted derivatives
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
ATE286395T1 (en) ANTITHRBOTIC AGENTS
SE0000303D0 (en) Novel compounds
HN2000000057A (en) DERIVATIVES OF I - TRIFLUOROMETIL-4-HIDROXI-7-PIPERIDINIL- AMINOMETILCROMANO.
CY1105142T1 (en) USE OF 6-DIMETHYLAMINOMETHYL-1-PHENYL-CYCLOHEXANE SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF URINARY INCONTINENCE